About this resource:
Source: U.S. Preventive Services Task Force
Last Reviewed: April 2022
The U.S. Preventive Services Task Force (USPSTF) recommends that the decision to initiate low-dose aspirin use to prevent cardiovascular disease (CVD) in adults ages 40 to 59 years who have a 10% or greater 10-year CVD risk should be individualized.
Current evidence indicates that the net benefit of aspirin use in this group is small. People who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are more likely to benefit.
USPSTF recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults age 60 years and older.
Objectives related to this resource (2)
Little or no detectable change
Suggested Citation
U.S. Preventive Services Task Force. (2022). Final update summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication.
